Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Tiebo Mao"'
Autor:
Weiyu Ge, Yanling Wang, Ming Quan, Tiebo Mao, Evelyne Y. Bischof, Haiyan Xu, Xiaofei Zhang, Shumin Li, Ming Yue, Jingyu Ma, Haiyan Yang, Lei Wang, Zhengyuan Yu, Liwei Wang, Jiujie Cui
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background Pancreatic adenocarcinoma (PC) is an aggressive malignancy with limited treatment options. The poor prognosis primarily stems from late-stage diagnosis and when the disease has become therapeutically challenging. There is an urgen
Externí odkaz:
https://doaj.org/article/d88ac45d46cb4a8a8f4f248cd3e0d370
Autor:
Yanling Wang, Weiyu Ge, Shengbai Xue, Jiujie Cui, Xiaofei Zhang, Tiebo Mao, Haiyan Xu, Shumin Li, Jingyu Ma, Ming Yue, Daiyuan Shentu, Liwei Wang
Publikováno v:
IET Systems Biology, Vol 17, Iss 4, Pp 174-186 (2023)
Abstract Cuproptosis is a novel cell death pathway, and the regulatory mechanism in pancreatic cancer (PC) is unclear. The authors aimed to figure out whether cuproptosis‐related lncRNAs (CRLs) could predict prognosis in PC and the underlying mecha
Externí odkaz:
https://doaj.org/article/d0bc4ead7e0e424d8231bea7743186f6
Autor:
Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Xiao Zhang, Weiyu Ge, Shumin Li, Jingyu Ma, Ming Yue, Shengbai Xue, Jiujie Cui, Liwei Wang
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC), as a highly lethal malignancy with high mortality, lacks of effective treatment. Canonical therapeutic targets in PDAC demand further verification among which HER2 receptor tyrosine kinase
Externí odkaz:
https://doaj.org/article/b0e3c4dedf7c4d4f833236d68ebaee49
Autor:
Xiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia, Shumin Li, Ming Yue, Jingyu Ma, Jiayu Yao, Yongchao Wang, Xiao Zhang, Shiqing Chen, Yuezong Bai, Yuexiang Wang, Xuebin Zhang, Qiang Liu, Yongwei Sun, Deliang Fu, Yingbin Liu, Lei Xiong, Liwei Wang
Publikováno v:
Cancer Communications, Vol 42, Iss 1, Pp 70-74 (2022)
Externí odkaz:
https://doaj.org/article/52309fee1f324715b8f44bfe7f1fb768
Autor:
Weiyu Ge, Daiyuan Shentu, Yongchao Wang, Yanling Wang, Shengbai Xue, Ming Yue, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Shumin Li, Jingyu Ma, Jiayu Yao, Jiujie Cui, Liwei Wang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Angiogenesis, a hallmark of cancer, is related to prognosis, tumor progression, and treatment response. Nevertheless, the correlation of angiogenesis-based molecular signature with clinical outcome and immune cell infiltration has not been thoroughly
Externí odkaz:
https://doaj.org/article/846e3e28f8d8482b99aaf6bb02f21b85
Autor:
Shengbai Xue, Weiyu Ge, Kexuan Wang, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Yongchao Wang, Jiayu Yao, Shumin Li, Ming Yue, Jingyu Ma, Yanling Wang, Daiyuan Shentu, Jiujie Cui, Liwei Wang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Pancreatic adenocarcinoma (PAAD) is one of the deadliest malignancies. Aging is described as the degeneration of physiological function, which is complexly correlated with cancer. It is significant to explore the influences of aging-related genes (AR
Externí odkaz:
https://doaj.org/article/96d3ea86bb7041bf88f8373f16bb37c0
Autor:
Jiujie Cui, Haiyan Yang, Jue Liu, Donghui Chen, Jiong Hu, Haiyan Zhang, Yu Wang, Ting Han, Tiebo Mao, Feng Jiao, Ewelina Biskup, Yaotian Pan, Min Liu, Liwei Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that lack of effective therapeutic drugs. K-001 is an oral antitumor drug made from active ingredients of marine microorganisms. The current study aimed to evaluate safet
Externí odkaz:
https://doaj.org/article/d3fb5544d43e4152b0d4b2aa009d412b
Autor:
Yu Wang, Yiyi Liang, Haiyan Xu, Xiao Zhang, Tiebo Mao, Jiujie Cui, Jiayu Yao, Yongchao Wang, Feng Jiao, Xiuying Xiao, Jiong Hu, Qing Xia, Xiaofei Zhang, Xujun Wang, Yongwei Sun, Deliang Fu, Lei Shen, Xiaojiang Xu, Jing Xue, Liwei Wang
Publikováno v:
Cell Discovery, Vol 7, Iss 1, Pp 1-17 (2021)
Abstract The current pathological and molecular classification of pancreatic ductal adenocarcinoma (PDAC) provides limited guidance for treatment options, especially for immunotherapy. Cancer-associated fibroblasts (CAFs) are major players of desmopl
Externí odkaz:
https://doaj.org/article/53b917ea03804ffd9adc703511da273d
Autor:
Weiyu Ge, Jingyu Ma, Tiebo Mao, Haiyan Xu, Xiaofei Zhang, Shumin Li, Yongchao Wang, Jiayu Yao, Ming Yue, Feng Jiao, Yu Wang, Meng Zhuo, Ting Han, Jiong Hu, Xiao Zhang, Jiujie Cui, Liwei Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPancreatic head cancer and pancreatic body/tail cancer are considered to have different clinical presentations and to have altered outcomes.MethodsNinety cases of pancreatic adenocarcinoma (PDAC) from our institution were used as a discover
Externí odkaz:
https://doaj.org/article/b82e8160f2ff40c4a0c38660471454a9
Autor:
Xiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia, Weiyu Ge, Shumin Li, Ming Yue, Jingyu Ma, Jiayu Yao, Yongchao Wang, Yanling Wang, Daiyuan Shentu, Xiao Zhang, Shiqing Chen, Yuezong Bai, Yuexiang Wang, Xuebin Zhang, Qiang Liu, Yongwei Sun, Deliang Fu, Yingbin Liu, Lei Xiong, Liwei Wang
Publikováno v:
EBioMedicine, Vol 77, Iss , Pp 103897- (2022)
Summary: Background: Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with an extremely poor prognosis. Effective targets for anticancer therapy confirmed in PDAC are limited. However, the characteristics of genomics have not been fully e
Externí odkaz:
https://doaj.org/article/20d94b8c046d4d87a62cdceba62b9a1b